Non–small cell lung cancer (NSCLC), which accounts for 85% of all cases of lung cancer,
includes the histologic subtypes of adenocarcinoma, squamous cell carcinoma, and large …

The radiographic evaluation and staging of bronehogenic carcinoma remains one of the
greatest challenges to the thoracic radiologist and one of his or her most important …

Correctly staging lung cancer is extremely important because the treatment options and the
prognosis differ significantly by stage. Several noninvasive imaging studies are available to …

Current procedures to determine the clinical staging of disease in patients with lung cancer
are lacking in accuracy, particularly regarding the presence of metastatic disease. We have …

Background. We evaluated the accuracy of computed tomography (CT) and positron-
emission tomography (PET) in the mediastinal staging of non-small cell lung cancer …

Aim: To determine whether PET/CT and brain MRI used in staging NSCLC can be accurate,
reliable and cost-effective tools. NSCLC represents 80–85% of lung cancer and adequate …

Integrated positron emission tomography (PET)/CT is routinely used for mediastinal nodal
staging of non-small cell lung carcinoma in centers throughout the world. This modality is the …

Staging classification in patients with non-small cell lung cancer does not always correlate
perfectly with surgical resectability. Therefore, it is important to evaluate individual features …

(eng) An ideal staging system should describe the extent of a disease as precisely as
possible, in order to give an optimal idea of prognosis and choice of treatment. Therefore …

PURPOSE: To meta-analytically compare 2-[fluorine 18] fluoro-2-deoxy-d-glucose positron
emission tomography (PET) and computed tomography (CT) for the demonstration of …